INNO-206
Showing 1 - 25 of 62
Malignant Solid Tumour Trial in Santa Monica (INNO-206)
Completed
- Malignant Solid Tumour
- INNO-206
-
Santa Monica, CaliforniaSarcoma Oncology Center
Jan 27, 2022
Advanced Solid Tumor Trial in Santa Monica (aldoxorubicin)
Completed
- Advanced Solid Tumor
-
Santa Monica, CaliforniaSarcoma Oncology Center
Jan 27, 2022
Advanced Solid Tumors Trial in Los Angeles (aldoxorubicin)
Completed
- Advanced Solid Tumors
-
Los Angeles, CaliforniaSamuel Oschin Comprehensive Cancer Institute
Jan 27, 2022
Metastatic Solid Tumors Trial in Scottsdale, Santa Monica (aldoxorubicin, gemcitabine)
Completed
- Metastatic Solid Tumors
-
Scottsdale, Arizona
- +1 more
Jan 27, 2022
Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma Trial in Santa Monica (aldoxorubicin, ifosfamide)
Completed
- Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma
-
Santa Monica, CaliforniaSarcoma Oncology Center
Jan 27, 2022
Kaposi's Sarcoma, HIV Positive, AIDS Trial in New Orleans (aldoxorubicin)
Completed
- Kaposi's Sarcoma
- +2 more
-
New Orleans, LouisianaLouisiana State University Health Science Center
Jan 27, 2022
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma Trial in Worldwide (Aldoxorubicin, Investigator's Choice
Completed
- Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
- Aldoxorubicin
- Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)
-
Birmingham, Alabama
- +73 more
Mar 28, 2022
Non Small Cell Lung Cancer Trial in El Segundo (Nab-paclitaxel, Cisplatin, 5Fluorouracil)
Withdrawn
- Non Small Cell Lung Cancer
- Nab-paclitaxel
- +14 more
-
El Segundo, CaliforniaChan Soon-Shiong Institute for Medicine
Mar 28, 2022
Melanoma Trial (ABP 206, FDA-licensed Nivolumab, EU-authorized Nivolumab)
Not yet recruiting
- Melanoma
- ABP 206
- +2 more
- (no location specified)
Jun 8, 2023
Achondroplasia Trial in Worldwide (BMN 111, Placebo)
Completed
- Achondroplasia
- BMN 111
- Placebo
-
Oakland, California
- +15 more
Dec 15, 2022
Organ Protection Trial (Lidocaine, Normal saline (NS))
Not yet recruiting
- Organ Protection
- Lidocaine
- Normal saline (NS)
- (no location specified)
Aug 13, 2022
Colorectal Tumor Trial in Shanghai
Recruiting
- Colorectal Neoplasm
-
Shanghai, Shanghai, ChinaRuijin hospital
Apr 15, 2022
Amputation, Upper Limb Trial (MyoTrain, Motor Imagery)
Not yet recruiting
- Amputation
- Upper Limb
- MyoTrain
- Motor Imagery
- (no location specified)
May 25, 2023
Gastritis Trial in Seoul (AD-206 20mg, Esomeprazole 20mg, AD-206 40mg)
Completed
- Gastritis
- AD-206 20mg
- +3 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 11, 2021
Rehabilitation Status of Cerebral Palsy and Anxiety of Their
Completed
- Cerebral Palsy
- +2 more
-
Istanbul, Atasehir, TurkeyPinar Akpinar
Jun 4, 2021
Health Literacy Level Trial in Ankara (Health Literacy Education)
Completed
- Health Literacy Level
- Health Literacy Education
-
Ankara, Çubuk, TurkeyAnkara Yıldırım Beyazıt University
May 5, 2021
Coronary Artery Disease Trial in Shenyang (Biolimus, Powerline)
Completed
- Coronary Artery Disease
- Biolimus
- Powerline
-
Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command
Sep 15, 2021
Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)
Not yet recruiting
- Unresectable Metastatic Colorectal Cancer
- ABBV-400
- +4 more
- (no location specified)
Oct 25, 2023
Fibromyalgia Trial in Seville (Extra Virgin Olive oil-supplemented Mediterranean Diet Intervention, Olive oil-supplemented
Active, not recruiting
- Fibromyalgia
- Extra Virgin Olive oil-supplemented Mediterranean Diet Intervention
- Olive oil-supplemented Mediterranean Diet Intervention
-
Seville, SpainPronacera Therapeutics Laboratory
Jun 27, 2023
Latent Tuberculosis Trial in Dourados (BCG)
Not yet recruiting
- Latent Tuberculosis
- BCG
-
Dourados, Mato Grosso Do Sul, BrazilRoberto Oliveira
Sep 13, 2022